JNJ241115P115000
- 0.05
- 0.000.00%
Johnson & Johnson Newsroom
Eli Lilly and Co and Johnson & Johnson have successively sued US institutions for obstructing pharmaceutical discount plans.
GLH November 18th | eli lilly and co has filed a lawsuit against the Health Resources and Services Administration (HRSA) of the usa, accusing them of trying unreasonably to block specific discount models offered by eli lilly for drugs supplied under the government's 340B program. Previously, johnson & johnson also filed a lawsuit for similar reasons. In a lawsuit filed on Thursday in federal court in Washington, DC, eli lilly accuses HRSA of lacking reasonable basis or procedures in trying to block its cash supplement models for 340B covered entities. Pharmaceutical companies participating in the 340B program are required to provide expensive outpatient drugs to medical care providers serving uninsured and low-income patients.
Halozyme Plans Finance $2.1 Takeover of Evotech in Cash: Report
The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.
Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.
US Manufacturing Index Rises To 43, Highest Since 2020
Income Investing: Cast a Wider Net With These High-Yield Dividend Aristocrats -- Barron's
Sell-off of US vaccine stocks intensifies! Analyst: Little Kennedy brings uncertainty to the entire industry.
1. On Friday Eastern Time, vaccine manufacturers' stocks plummeted as Donald Trump selected vaccine skeptic Kennedy as Health Secretary, causing industry uncertainty. Moderna, Novavax, Pfizer, and other stock prices were all affected. 2. Analysts pointed out that Kennedy's anti-vaccine stance may weaken public trust in vaccines, leading to a decrease in the vaccination rate in the USA, increasing the risk of outbreaks of diseases such as measles and whooping cough.
Catalyst Watch: Nvidia Earnings, Microsoft Ignite, Crypto Confidence, and P&G Event
U.S. Pharma Is Largely Immune From 'MAHA' Impact: Wolfe
Johnson & Johnson (JNJ) Guggenheim Global Healthcare Conference (Transcript)
Medtech Shouldn't Be Greatly Impacted by RFK Jr. at HHS, Wells Fargo Says
This Is What Whales Are Betting On Johnson & Johnson
CHMP Recommends Approval Of Janssen's Rybrevant (Amivantamab) And Lazcluze (Lazertinib) Combo For First-Line Treatment Of EGFR-Mutated Advanced NSCLC, Potentially Establishing New Standard Of Care Pending European Commission Approval
Least Shorted S&P 500 Stocks in October
Eli Lilly and Co (LLY.US) and Johnson & Johnson (JNJ.US) have successively sued American institutions for obstructing pharmaceutical discount plans.
Eli Lilly and Co has filed a lawsuit against the United States Health Resources and Services Administration, accusing them of unreasonably trying to block Eli Lilly's specific discounting scheme for drugs supplied under the government's 340B program.
This Johnson & Johnson Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Express News | EMA's Chmp: Lazcluze (Lazertinib) Received a Positive Opinion
Johnson & Johnson Initiated at Outperform by Wolfe Research
Johnson & Johnson Analyst Ratings
The top institutions have disclosed their Q3 US stock hold positions! They are still heavily invested in technology stocks, but some signs are emerging.
Recently, the 13F reports of institutional investors in the US stock market have been released one after another, becoming an important channel for outsiders to understand the investment trends on Wall Street.
Vaccines stocks in the usa collectively plummet! Trump surprisingly appoints an anti-vaccine advocate as the Secretary of Health in the usa.
① Trump nominated Robert F. Kennedy Jr. as the new Secretary of Health and Human Services, which triggered a sell-off in vaccine companies; ② Kennedy advocates very radical views, opposing vaccines since 2005, and questioning the transparency of the usa government in public health information.